Qube Research & Technologies (QRT)
RCEL icon

Qube Research & Technologies (QRT)’s Avita Medical RCEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
+63,784
New +$275K ﹤0.01% 2826
2023
Q2 		– Sell
-56,039
Closed -$783K – 2896
2023
Q1 		$783K Buy
56,039
+33,474
+148% +$356K ﹤0.01% 1388
2022
Q4 		$149K Buy
22,565
+4,461
+25% +$26.7K ﹤0.01% 1901
2022
Q3 		$95K Sell
18,104
-3,949
-18% -$24.4K ﹤0.01% 1985
2022
Q2 		$105K Buy
+22,053
New +$136K ﹤0.01% 1937
2021
Q2 		– Sell
-22,796
Closed -$452K – 2711
2021
Q1 		$452K Sell
22,796
-39,775
-64% -$925K 0.01% 1235
2020
Q4 		$1.16M Buy
+62,571
New +$1.37M 0.02% 828
2020
Q1 		– Sell
-3,331
Closed -$152K – 1561
2019
Q4 		$152K Buy
+3,331
New +$138K ﹤0.01% 1428

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RCEL Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Avita Medical (RCEL) in Q2 2026: 63,784 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #2826 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in RCEL as recently as Q1 2023.

Qube Research & Technologies (QRT) first reported a position in RCEL in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.16M in Q4 2020. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Qube Research & Technologies (QRT) held 63,784 shares of Avita Medical worth $263K as of Q2 2026.
  • Avita Medical was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Avita Medical made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2826 holding.
  • Qube Research & Technologies (QRT) first reported a position in Avita Medical in Q4 2019 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s Avita Medical position peaked at $1.16M in Q4 2020.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.